BERNARD AMOR, M.D.; ANDRÉ KAHAN, M.D.; MAXIME DOUGADOS, M.D.; FRANÇOIS DELRIEU, M.D.
To the editor: We read with interest the review on sulfasalazine by Peppercorn (1). We write to suggest another indication for use of sulfasalazine.
We have evaluated the therapeutic effect of sulfasalazine in the treatment of ankylosing spondylitis. Eight patients (mean age, 29 years; 5 male, 3 female) with classic ankylosing spondylitis and peripheral arthritis (2), whose active disease was not adequately controlled by non-steroidal anti-inflammatory drugs, were included in an open trial. Two patients had transient diarrhea but no roentgenographic or sigmoidoscopic evidence of ulcerative colitis or Crohn's disease. None of the patients had psoriasis or Reiter's
AMOR B, KAHAN A, DOUGADOS M, DELRIEU F. Sulfasalazine and Ankylosing Spondylitis. Ann Intern Med. ;101:878. doi: 10.7326/0003-4819-101-6-878_1
Download citation file:
Published: Ann Intern Med. 1984;101(6):878.
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use